International Journal of Cancer Management

Published by: Kowsar

Central Nervous System Toxoplasmosis in Relapsed Hodgkin’s Lymphoma: A Case Report

Hassan Abolghasemi 1 , Ehsan Shahverdi 2 , * , Ramezan Jafari 3 , Fardin Dolatimehr 4 and Azam Khandani 5
Authors Information
1 Department of Pediatrics, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
2 Blood Transfusion Research Center/High Institute for Research Center & Education in Transfusion Medicine, Immunohematology Department, Tehran, IR Iran
3 Department of Radiology, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
4 Students’ Research Committee (SRC), Baqiyatallah University of Medical Sciences, Tehran, IR Iran
5 Islamic Azad University of Nursing Sciences, Najafabad, Esfahan, IR Iran
Article information
  • Iranian Journal of Cancer Prevention: August 2016, 9 (4); e5810
  • Published Online: June 11, 2016
  • Article Type: Case Report
  • Received: February 27, 2016
  • Revised: April 10, 2016
  • Accepted: June 5, 2016
  • DOI: 10.17795/ijcp-5810

To Cite: Abolghasemi H, Shahverdi E, Jafari R, Dolatimehr F, Khandani A. Central Nervous System Toxoplasmosis in Relapsed Hodgkin’s Lymphoma: A Case Report, Int J Cancer Manag. 2016 ; 9(4):e5810. doi: 10.17795/ijcp-5810.

Abstract
Copyright © 2016, Iranian Journal of Cancer Prevention. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
Acknowledgements
Footnotes
References
  • 1. Ruskin J, Remington JS. Toxoplasmosis in the compromised host. Ann Intern Med. 1976; 84(2): 193-9[PubMed]
  • 2. Vietzke WM, Gelderman AH, Grimley PM, Valsamis MP. Toxoplasmosis complicating malignancy. Experience at the National Cancer Institute. Cancer. 1968; 21(5): 816-27[PubMed]
  • 3. Gleason TH, Hamlin WB. Disseminated toxoplasmosis in the compromised host. A report of five cases. Arch Intern Med. 1974; 134(6): 1059-62[PubMed]
  • 4. Masson R, Fiere D, Lahneche B, Cordat C, Berger F, Revol L. [Encephalic pseudotumoral toxoplasmosis in the course of blood diseases]. Nouv Presse Med. 1975; 4(35): 2499-502[PubMed]
  • 5. Sarbach B. [Cerebral complications (viral encephalopathy, toxoplasmosis) in two patients with treated Hodgkin's disease. Clinical and pathological study (author's transl)]. Acta Neurol Belg. 1975; 75(2): 65-84[PubMed]
  • 6. Vallat M, Pesme D, Durand M, Hoerni B. [Acquired toxoplasmosis during the course of Hodgkin's disease]. Nouv Presse Med. 1976; 5(38): 2543-4[PubMed]
  • 7. Anderson SE, Remington JS. The diagnosis of toxoplasmosis. South Med J. 1975; 68(11): 1433-43[PubMed]
  • 8. Townsend JJ, Wolinsky JS, Baringer JR, Johnson PC. Acquired toxoplasmosis. A neglected cause of treatable nervous system disease. Arch Neurol. 1975; 32(5): 335-43[PubMed]
  • 9. Halonen SK, Chiu F, Weiss LM. Effect of cytokines on growth of Toxoplasma gondii in murine astrocytes. Infect Immun. 1998; 66(10): 4989-93[PubMed]
  • 10. Silva LA, Vieira RS, Serafini LN, Carlotti CGJr, Figueiredo JF. [Toxoplasmosis of the central nervous system in a patient without immunosupression: case report]. Rev Soc Bras Med Trop. 2001; 34(5): 487-90[PubMed]
  • 11. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb Mortal Wkly Rep. 1993; 41: 1-10
  • 12. Pulivarthi S, Reshi RA, McGary CT, Gurram MK. Cerebral toxoplasmosis in a patient on methotrexate and infliximab for rheumatoid arthritis. Intern Med. 2015; 54(11): 1433-6[DOI][PubMed]
  • 13. Safa G, Darrieux L. Cerebral toxoplasmosis after rituximab therapy. JAMA Intern Med. 2013; 173(10): 924-6[DOI][PubMed]
  • 14. Young JD, McGwire BS. Infliximab and reactivation of cerebral toxoplasmosis. N Engl J Med. 2005; 353(14): 1530-1[DOI][PubMed]
  • 15. Pereira-Chioccola VL, Vidal JE, Su C. Toxoplasma gondii infection and cerebral toxoplasmosis in HIV-infected patients. Future Microbiol. 2009; 4(10): 1363-79[DOI][PubMed]
  • 16. Madi D, Achappa B, Rao S, Ramapuram JT, Mahalingam S. Successful treatment of cerebral toxoplasmosis with clindamycin: a case report. Oman Med J. 2012; 27(5): 411-2[DOI][PubMed]
  • 17. Roemer E, Blau IW, Basara N, Kiehl MG, Bischoff M, Gunzelmann S, et al. Toxoplasmosis, a severe complication in allogeneic hematopoietic stem cell transplantation: successful treatment strategies during a 5-year single-center experience. Clin Infect Dis. 2001; 32(1)-8[DOI][PubMed]
  • 18. Yapar N, Erdenizmenli M, Oguz VA, Cakir N, Yuce A. Cerebral toxoplasmosis treated with clindamycin alone in an HIV-positive patient allergic to sulfonamides. Int J Infect Dis. 2005; 9(1): 64-6[DOI][PubMed]
  • 19. Patil HV, Patil VC, Rajmane V, Raje V. Successful treatment of cerebral toxoplasmosis with cotrimoxazole. Indian J Sex Transm Dis. 2011; 32(1): 44-6[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments